Capital Research Global Investors 13D/13G Filings for Sarepta Therapeutics, Inc. (SRPT)

Capital Research Global Investors 13D and 13G filings for Sarepta Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-08-10
12:21 pm
Sale
2021-08-1013GSAREPTA THERAPEUTICS INC
SRPT
Capital Research Global Investors3,842,491
4.800%
-4,181,639decrease
(-52.11%)
Filing